MAPT and Alzheimer disease: In the responder group, the concentration of total tau protein decreased after 72 h, which indicated that following the initial washout of this marker characteristic of neurofibrillary neurodegeneration, its concentration in patients without AD comorbidity in the lumbar CSF sample stabilizes.